Beijing Konruns Pharmaceutical Co (SHSE:603590) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603590 Beijing Konruns Pharmaceutical Co Ltd SHSE:603590
79 GF Score
Price ¥29.50
GF Value ¥35.27
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Beijing Konruns Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:603590
79GF Score
Beijing Konruns Pharmaceutical Co Ltd SHSE:603590
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Konruns Pharmaceutical Co (SHSE:603590) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Konruns Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥29.50 is trading 16.4% below its estimated GF Value™ of ¥35.27. GuruFocus considers Beijing Konruns Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603590:

  • FFO:
  • GF Value™: ¥35.27 vs. price of ¥29.50 (16.4% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603590 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Konruns Pharmaceutical Co Business Description

Address Building 3, No. 7 Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of inventive drugs, and is oriented to clinical needs.
79GF Score

Get the complete analysis for SHSE:603590

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.50
Price
¥35.27
GF Value